Thrombocytopenia in the antiphospholipid syndrome.
Galli
M
M
Department of Haematology, Ospedali Riuniti, Bergamo, Italy.
Finazzi
G
G
Barbui
T
T
D017152:Antibodies, Antiphospholipid / Q000378:metabolism; D000925:Anticoagulants / Q000627:therapeutic use; D016736:Antiphospholipid Syndrome / Q000175:diagnosis* / Q000378:metabolism; D001792:Blood Platelets / Q000378:metabolism; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D007377:Interleukin-3 / Q000009:adverse effects / Q000627:therapeutic use; D011993:Recombinant Fusion Proteins / Q000009:adverse effects / Q000627:therapeutic use; D013921:Thrombocytopenia / Q000188:drug therapy / Q000209:etiology* / Q000378:metabolism; D013927:Thrombosis / Q000150:complications / Q000378:metabolism
D017152:Antibodies, Antiphospholipid; D000925:Anticoagulants; D007377:Interleukin-3; C078524:PIXY321 fusion protein, recombinant; D011993:Recombinant Fusion Proteins; D016178:Granulocyte-Macrophage Colony-Stimulating Factor